Beryl Drugs Ltd. - Research Center
524606 BERLDRG Group (XT) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 22 | Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | |
|---|---|---|---|---|---|
| Sales | 7.69 | 4.93 | 3.47 | 3.18 | 3.34 |
| Operating profit | 0.42 | 0.56 | -0.34 | 0.21 | -0.13 |
| Interest | 0.11 | 0.13 | 0.10 | 0.12 | 0.11 |
| Gross profit | 0.52 | 0.47 | -0.39 | 0.13 | -0.20 |
| EPS (Rs) | 0.67 | 0.43 | -0.94 | -0.20 | -0.83 |
Quarterly
results in details
| Sep' 22 | Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | |
|---|---|---|---|---|---|
| Other income | 0.21 | 0.04 | 0.05 | 0.04 | 0.04 |
| Stock adjustment | 0.23 | -0.25 | -0.40 | 0.01 | 0.13 |
| Raw material | 4.35 | 2.83 | 2.79 | 1.71 | 1.75 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.44 | 0.33 | 0.29 | 0.39 | 0.33 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 2.25 | 1.46 | 1.13 | 0.86 | 1.27 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.19 | 0.25 | 0.27 | 0.27 | 0.24 |
| Taxation | -0.02 | - | -0.18 | -0.04 | -0.03 |
| Net profit / loss | 0.34 | 0.22 | -0.47 | -0.10 | -0.42 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 5.41 | 11.32 | -9.77 | 6.50 | -3.88 |
| GPM (%) | 6.55 | 9.43 | -10.99 | 4.03 | -6.02 |
| NPM (%) | 4.32 | 4.39 | -13.48 | -3.17 | -12.49 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis